072020 — Choong Ang Vaccine Laboratory Share Price
0.000.00%
Last trade - 00:00- KR₩99bn
- KR₩82bn
- KR₩42bn
- 81
- 56
- 56
- 76
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.99 | ||
| Price to Tang. Book | 1 | ||
| Price to Free Cashflow | 9.16 | ||
| Price to Sales | 2.36 | ||
| EV to EBITDA | 6.6 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.52% | ||
| Return on Equity | 6.15% | ||
| Operating Margin | 16.66% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 32,902.92 | 36,317.53 | 40,913.9 | 39,299.16 | 41,867.97 | n/a | n/a | 4.78% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -18.3 | +30.03 | +78.13 | -42.15 | +53.06 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Choong Ang Vaccine Laboratory Co., Ltd. is a Korea-based company mainly engaged in the manufacturing and marketing of veterinary vaccines. The Company provides veterinary vaccines for fowl, dogs, pigs, cattle, rabbits, cats, fishes and others under the brand name SuiShot, PoulShot, Canishot, BoviShot, FeliShot, RabbiShot and AquaShot. The Company also provides diagnosis services, and distributes other veterinary drugs, such as antibiotics, anthelmintics, disinfectants and feed additives. The Company distributes its products within domestic market and to overseas markets.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- October 4th, 1994
- Public Since
- October 31st, 2003
- No. of Shareholders
- 15,062
- No. of Employees
- 178
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 9,357,374
- Address
- 1476-37, Yuseong-daero, Yuseong-gu, DAEJEON, 34055
- Web
- https://cavac.co.kr/
- Phone
- +82 428700526
- Auditors
- Donghyun Accounting Corp
Upcoming Events for 072020
Q2 2024 Choong Ang Vaccine Laboratory Earnings Release
Similar to 072020
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
Ahn-Gook Pharmaceutical Co
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
Aminologics Co
Korea Exchange - KOSDAQ
FAQ
What is the Choong Ang Vaccine Laboratory share price?
As of Today at 19:05 UTC, shares in Choong Ang Vaccine Laboratory are trading at KR₩10,560. This share price information is delayed by 15 minutes.
How has the Choong Ang Vaccine Laboratory share price performed this year?
Shares in Choong Ang Vaccine Laboratory last closed at KR₩10,560 and the price had moved by -1.77% over the past 365 days. In terms of relative price strength the Choong Ang Vaccine Laboratory share price has underperformed the FTSE Developed Asia Pacific Index by -1.09% over the past year.
What are the analyst and broker recommendations for Choong Ang Vaccine Laboratory?
The overall consensus recommendation for Choong Ang Vaccine Laboratory is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Choong Ang Vaccine Laboratory dividend yield?
The Choong Ang Vaccine Laboratory dividend yield is 1.42% based on the trailing twelve month period.
Does Choong Ang Vaccine Laboratory pay a dividend?
Last year, Choong Ang Vaccine Laboratory paid a total dividend of KR₩150, and it currently has a trailing dividend yield of 1.42%.Looking ahead, the next dividend pay date is 2024-04-19.
When does Choong Ang Vaccine Laboratory next pay dividends?
We do not have data on when Choong Ang Vaccine Laboratory is to next pay dividends. The historic dividend yield on Choong Ang Vaccine Laboratory shares is currently 1.42%.
How do I buy Choong Ang Vaccine Laboratory shares?
To buy shares in Choong Ang Vaccine Laboratory you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Choong Ang Vaccine Laboratory?
As of the previous close price of KR₩10,560, shares in Choong Ang Vaccine Laboratory had a market capitalisation of KR₩99bn.
Where are Choong Ang Vaccine Laboratory shares listed?
Here are the trading details for Choong Ang Vaccine Laboratory:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 072020
What kind of share is Choong Ang Vaccine Laboratory?
Based on an overall assessment of its quality, value and momentum Choong Ang Vaccine Laboratory is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Choong Ang Vaccine Laboratory share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Choong Ang Vaccine Laboratory share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Choong Ang Vaccine Laboratory. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -8.1%.
As of the last closing price of KR₩10,560, shares in Choong Ang Vaccine Laboratory were trading -2.62% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Choong Ang Vaccine Laboratory PE Ratio?
The Choong Ang Vaccine Laboratory PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩10,560.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Choong Ang Vaccine Laboratory?
Choong Ang Vaccine Laboratory's management team is headed by:
- Yin Jung Yoon - CEO
- Seung Gi Park - OTH
- Seung Yong Choi - OTH
- Bong Hyeok Jang - DRC